DR. CHARLES YANG

Drug development is a complex and lengthy process. In the past few decades, industry had been focusing on investing new technology to screen targets and identify molecules to drug the undraggables. Yet, the percentage of success remains low. This presentation will cover the drug development from candidate optimization to the earlyclinical development. How Modeling can be implemented to accelerate formulation development for Chemically synthesized modalities.